WHO ICTRP trial
The role and mechanism of LDLR in the occurrence and development of AML
ChiCTR2500114283 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500114283 |
|---|---|
| Public title | The role and mechanism of LDLR in the occurrence and development of AML |
| Scientific title | The role and mechanism of LDLR in the occurrence and development of AML |
| Primary sponsor | The Affiliated Yongchuan Hospital of Chongqing Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Acute myeloid leukemia |
| Interventions | Acute myeloid Leukemia Observation Group:None |
| Registration date | Dec 10, 2025 |
| Target size | Acute myeloid Leukemia Observation Group:15 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: